Myriad Genetics Inc (MYGN)
Inventory turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2020 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 747,600 | 584,300 | 614,100 | 681,800 | 628,500 |
Inventory | US$ in thousands | 22,000 | 20,100 | 15,300 | 29,100 | 31,400 |
Inventory turnover | 33.98 | 29.07 | 40.14 | 23.43 | 20.02 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $747,600K ÷ $22,000K
= 33.98
Inventory turnover is a key financial ratio that measures how efficiently a company manages its inventory. It is calculated by dividing the cost of goods sold by the average inventory for a specific period. Higher inventory turnover ratios indicate that the company is selling its inventory quickly and efficiently.
In the case of Myriad Genetics, Inc., we can observe fluctuations in the inventory turnover ratio over the past five years. In 2023, the inventory turnover ratio was 10.74, which indicates that the company's inventory turned over approximately 10.74 times during the year. This represents an increase from the previous year's ratio of 10.05.
Comparing to 2021, where the ratio was 12.92, there has been a decrease in the inventory turnover efficiency in 2023. However, the ratio remains relatively high, suggesting that Myriad Genetics is managing its inventory efficiently.
Looking back to 2020 and 2019, both years had the same inventory turnover ratio of 6.40. This indicates that the company's inventory turnover improved significantly from those earlier years.
Overall, the trend in Myriad Genetics' inventory turnover ratio shows some variability but generally remains at a level that demonstrates effective management of its inventory. It is important for the company to continue monitoring and optimizing its inventory levels to ensure continued operational efficiency.
Peer comparison
Dec 31, 2023